Skip to main content
. 2019 Oct 2;14(10):e0222786. doi: 10.1371/journal.pone.0222786

Table 2. Clinical and follow-up characteristics and the occurrence of directly observed therapy among cases of TB/HIV coinfection in Porto Alegre, 2009–2013.

Characteristics Totalb Receiving DOTa p-value
Yes No
Type of entry <0.001*
New case 1382 (57.6%) 175 (12.7%) 1207 (87.3%)
Relapse 347 (14.5%) 65 (18.7%) 282 (81.3%)
Readmission after default 615 (25.6%) 146 (23.7%) 469 (76.3%)
Transfer 56 (2.3%) 20 (35.7%) 36 (64.3%)
Chest X-ray 0.279*
Suspicion 2137 (89.2%) 366 (17.1%) 1771 (82.9%)
Normal 56 (2.3%) 9 (16.1%) 47 (83.9%)
Other pathology 29 (1.2%) 1 (3.4%) 28 (96.6%)
Not performed 173 (7.2%) 29 (16.8%) 144 (83.2%)
1st sputum AFB testc 0.002*
Positive 1414 (58.9%) 268 (19%) 1146 (81%)
Negative 687 (28.6%) 105 (15.3%) 582 (84.7%)
Not performed 299 (12.5%) 33 (11%) 266 (89%)
2nd sputum AFB testc 0.003*
Positive 1001 (41.7%) 195 (19.5%) 806 (80.5%)
Negative 661 (27.6%) 112 (16.9%) 549 (83.1%)
Not performed 736 (30.7%) 98 (13.3%) 638 (86.7%)
Indication for DOTa <0.001**
Yes 618 (25.8%) 318 (51.5%) 300 (48.5%)
No 1778 (74.2%) 87 (4.9%) 1691 (95.1%)
Alcohol abuse <0.001**
Yes 613 (25.6%) 149 (24.3%) 464 (75.7%)
No 1784 (74.4%) 257 (14.4%) 1527 (85.6%)
Diabetes 0.508**
Yes 66 (2.8%) 13 (19.7%) 53 (80.3%)
No 2330 (97.2%) 392 (16.8%) 1938 (83.2%)
Mental disorders <0.001**
Yes 97 (4.1%) 34 (35.1%) 63 (64.9%)
No 2297 (95.9%) 370 (16.1%) 1927 (83.9%)
Status at completion <0.001*
Cure 852 (35.7%) 148 (17.4%) 704 (82.6%)
Default 855 (35.8%) 159 (18.6%) 696 (81.4%)
Death 532 (22.2%) 54 (10.2%) 478 (89.8%)
Transfer 87 (3.6%) 18 (20.7%) 69 (79.3%)
MDR-TBd 62 (2.6%) 22 (35.5%) 40 (64.5%)
Total 2400 (100%) 406 (17%) 1994 (83%)

Homogeneity of proportions test based on Pearson’s chi-square statistic* or Fischer’s exact test**.

aDOT = Directly observed therapy,

btotal data may differ due to the possibility of the non-response by participants,

cAFB test = acid-fast bacilli test,

dMDR-TB = Multidrug-resistant TB.